Medical Device | March 30, 2022
Medtronic commences PRAAN registry for stroke patients
The registry will be conducted for approximately two and a half years and up to 200 subjects will be enrolled
The registry will be conducted for approximately two and a half years and up to 200 subjects will be enrolled
Tardive dyskinesia (TD) is a movement disorder that is characterized by uncontrollable, abnormal and repetitive movements of the face, torso and/or other body parts, which may be disruptive and negatively impact patients
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
Blood contains a mixture of exosomes secreted from nearly all tissues and cells, and exosomes from other tissues can mask changes caused by disease, making it difficult to detect the presence of biomarkers that reflect disease
First and only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder (CDD) in patients two years of age and older
Experts will speak about primary tumours of the nervous system and also the tumours of other body parts which get metastasized to the nervous system
Agreement builds on previous Novartis success using emerging technologies to develop first-in-class gene therapies for neurological disorders
Neural sleeve first algorithm-powered bionic garment designed to help those with mobility issues due to multiple sclerosis, stroke, cerebral palsy, and other conditions, regain functional movement in everyday activities
The NMPA Breakthrough Therapy Designation was based on results from the Phase 2 TRUST trial of ROS1 fusion-positive NSCLC patients treated with taletrectinib, a new generation of potent ROS1 inhibitors
Company has bought 7.73 million shares for KRW 146.1 billion thus securing the largest shareholder status in Bukwang Pharmaceutical
Subscribe To Our Newsletter & Stay Updated
